Modern genomic techniques are emerging as useful tools in resolving current relatively crude clinical syndromes, but until we are able to define preclinical or even prepathological endophenotypes, the predictive goals of modern medicine are unlikely to be realized. This will require much more systematic exploration of phenotypic space and similar approaches to the definition of a vast range of stimuli that are currently unmeasured.
